Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

ALCSI: Raising lung cancer screening awareness in the US

Priyanka Senthil - American Lung Cancer Screening Initiative
ALCSI: Raising lung cancer screening awareness in the US ( Priyanka Senthil - American Lung Cancer Screening Initiative )
17 Jun 2021

OncoAlert and ecancer ASCO roundup - Day 4 and 5

Dr Gil Morgan - Skåne University Hospital in Lund, Sweden
OncoAlert and ecancer ASCO roundup - Day 4 and 5 ( Dr Gil Morgan - Skåne University Hospital in Lund, Sweden )
16 Jun 2021

ADT plus TAK-700 with ADT plus bicalutamide in patients with newly diagnosed mHSPC

Prof Neeraj Agarwal - Huntsman Cancer Institute, University of Utah, Salt Lake City, USA
ADT plus TAK-700 with ADT plus bicalutamide in patients with newly diagnosed mHSPC ( Prof Neeraj Agarwal -  Huntsman Cancer Institute, University of Utah, Salt Lake City, USA )
15 Jun 2021

A comparison of clinical outcomes from ZUMA-5 and the international scholar-5 external control cohort in R/R FL

Prof Paola Ghione - Roswell Park Comprehensive Cancer Center, Buffalo, USA
A comparison of clinical outcomes from ZUMA-5 and the international scholar-5 external control cohort in R/R FL ( Prof Paola Ghione - Roswell Park Comprehensive Cancer Center, Buffalo, USA )
15 Jun 2021

GLOW: Fixed-duration ibrutinib and venetoclax for first-line CLL

Prof Arnon Kater - Amsterdam University Medical Centre, Amsterdam, The Netherlands
GLOW: Fixed-duration ibrutinib and venetoclax for first-line CLL ( Prof Arnon Kater - Amsterdam University Medical Centre, Amsterdam, The Netherlands )
15 Jun 2021

Brentuximab vedotin with chemotherapy for advanced classical Hodgkin lymphoma

Dr Martin Hutchings - Copenhagen University Hospital, Copenhagen, Denmark
Brentuximab vedotin with chemotherapy for advanced classical Hodgkin lymphoma ( Dr Martin Hutchings - Copenhagen University Hospital, Copenhagen, Denmark )
15 Jun 2021

Pembrolizumab plus trastuzumab and chemotherapy for HER2+ metastatic gastric or gastroesophageal junction cancer

Dr Yelena Janjigian - Memorial Sloan Kettering Center, New York, USA
Pembrolizumab plus trastuzumab and chemotherapy for HER2+ metastatic gastric or gastroesophageal junction cancer ( Dr Yelena Janjigian - Memorial Sloan Kettering Center, New York, USA )
14 Jun 2021

Using a novel cervical precancer screening approach to detect HPV in incarcerated women in Ghana

Dr Kofi Effah, Catholic Hospital, Battor, Ghana
Using a novel cervical precancer screening approach to detect HPV in incarcerated women in Ghana ( Dr Kofi Effah, Catholic Hospital, Battor, Ghana )
14 Jun 2021

Real world evidence on the use of antibody drug conjugates in peripheral T-cell lymphoma

Prof Ali Bazarbachi - American University of Beirut-Medical Center, Beirut, Lebanon
Real world evidence on the use of antibody drug conjugates in peripheral T-cell lymphoma ( Prof Ali Bazarbachi - American University of Beirut-Medical Center, Beirut, Lebanon )
14 Jun 2021

Primary analysis from the OPTIC trial, a dose-ranging study of ponatinib for CP-CML

Dr Jorge Cortes - Georgia Cancer Center, Augusta, USA
Primary analysis from the OPTIC trial, a dose-ranging study of ponatinib for CP-CML ( Dr Jorge Cortes - Georgia Cancer Center, Augusta, USA )
11 Jun 2021

Marizomib in combination with temozolomide-based radiochemotherapy for newly diagnosed glioblastoma

Dr Patrick Roth - University Hospital Zurich, Zurich, Switzerland
Marizomib in combination with temozolomide-based radiochemotherapy for newly diagnosed glioblastoma ( Dr Patrick Roth - University Hospital Zurich, Zurich, Switzerland )
11 Jun 2021

Pembrolizumab improves on chemo in MSI-H/dMMR mCRC

Prof Thierry André - Sorbonne University and Saint-Antoine Hospital, Paris, France
Pembrolizumab improves on chemo in MSI-H/dMMR mCRC ( Prof Thierry André - Sorbonne University and Saint-Antoine Hospital, Paris, France )
11 Jun 2021